[DOI] [PubMed] [Google Scholar] 84.Yeh L.S., Gregory C.R., Theriault B.R., Hou S.M., Lecouter R.A
Rutjes A, Denton D, Di Nisio M, Chong L, Abraham R, Al-Assaf A, Anderson J, Malik M, Vernooij R, Martnez G, Tabet N, McCleery J
While research on BPC-157, particularly in France human trials, is ongoing and has shown promising results, it is primarily available for research purposes
See our blog titled FDA Clarifies Policies for Pharmacy Compounders of GLP-1 Products. Foley is here to help you address the short- and long-term impacts in the wake of regulatory changes
Some experts even raise concerns that, while no study has shown BPC-157 causes cancer in humans, the connection is "currently theoretical but plausible given the lack of comprehensive human studies." This highlights a critical point: without thorough research, youre taking a gamble on your health